The excretion of coproporphyrin isomers I and III was studied in the rat. Both isomers were found to bind equally to rat plasma and liver cytosol in vitro and to disappear from plasma at equal rates after single injections in vivo. During equimolar infusions of isomers into bile fistula animals, both the I and III isomers were excreted in bile in a concentration ratio of 2:1, respectively. Pretreatment of animals with ethinylestradiol or simultaneous infusions of phenoldibromophthalein disulfonate caused a reduction in total hepatic excretion with no change in the 2:1 ratio in bile. As hepatic excretion fell, excretion of both isomers in urine rose, with an increase in the proportion of the I isomer. The findings mimic those reported to occur in man and can be explained by inhibition of a common carrier which requires a stereospecific configuration that statistically favors the hepatic transport of the symmetrical coproporphyrin I isomer.
Neil Kaplowitz, Norman Javitt, Attallah Kappas
Title and authors | Publication | Year |
---|---|---|
Potential amelioration of liver function by low-dose tolvaptan in heart failure patients
Mino Y, Hoshikawa K, Naito T, Akutsu S, Imoto Y, Nakatsugawa E, Saotome M, Maekawa Y, Kawakami J |
Toxicology Reports | 2025 |
Plasma and urinary CP I and CP III concentrations in chimeric mice with human hepatocytes after rifampicin administration
Shishido Y, Yoshida T, Oshida K, Uchida M |
Pharmacology Research & Perspectives | 2024 |
Urinary coproporphyrins as a diagnostic biomarker of Dubin-Johnson syndrome in neonates: A diagnostic pathway is proposed.
Al-Hussaini A, Asery A, Alharbi O |
Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association | 2023 |
The pharmacokinetics of oral trazpiroben (TAK-906) after organic anion transporting polypeptide 1B1/1B3 inhibition: A phase I, randomized study.
Mukker JK, Dukes G, Tolkoff M, Wang L, Almansa C, Huh SY, Nishihara M, Ramsden D, Chen C |
Clinical and Translational Science | 2022 |
Benign inheritable disorders of bilirubin metabolism manifested by conjugated hyperbilirubinemia-A narrative review.
Morais MB, Machado MV |
United European gastroenterology journal | 2022 |
Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation
Y Li, Z Talebi, X Chen, A Sparreboom, S Hu |
Molecules (Basel, Switzerland) | 2021 |
Endogenous Coproporphyrin I and III are Altered in Multidrug Resistance-Associated Protein 2-Deficient (TR−) Rats
J Bezençon, C Saran, J Hussner, JJ Beaudoin, Y Zhang, H Shen, JK Fallon, PC Smith, HE zu Schwabedissen, KL Brouwer |
Journal of Pharmaceutical Sciences | 2021 |
Further Evaluation of Coproporphyrins as Clinical Endogenous Markers for OATP1B
S Feng, Q Bo, HA Coleman, JE Charoin, M Zhu, J Xiao, Y Jin |
Journal of clinical pharmacology | 2021 |
Congenital erythropoietic protoporphyria and protoporphyric hepatopathy in a dog
BC Kunz, SA Center, JF Randolph, JD Walker, AE Choi, KE Anderson |
Journal of the American Veterinary Medical Association | 2020 |
The Liver: Biology and Pathobiology
IM Arias, HJ Alter, JL Boyer, DE Cohen, DA Shafritz, SS Thorgeirsson, AW Wolkoff |
2020 | |
Absorption and Disposition of Coproporphyrin I (CPI) in Cynomolgus Monkeys and Mice: Pharmacokinetic Evidence to Support the Use of CPI to Inform the Potential for Organic Anion-Transporting Polypeptide Inhibition
X Gu, L Wang, J Gan, RM Fancher, Y Tian, Y Hong, Y Lai, M Sinz, H Shen |
Drug Metabolism and Disposition | 2020 |
Quantitative assessment of the risk of OATP1B1/1B3-mediated drug-drug interactions
D Mori, K Maeda, H Kusuhara |
Folia Pharmacologica Japonica | 2019 |
Biomarkers for In Vivo Assessment of Transporter Function
F Müller, A Sharma, J König, MF Fromm, MC Michel |
Pharmacological reviews | 2018 |
Clinical Investigation of Coproporphyrins as Sensitive Biomarkers to Predict Mild to Strong OATP1B-Mediated Drug–Drug Interactions
A Kunze, EN Ediage, L Dillen, M Monshouwer, J Snoeys |
Clinical Pharmacokinetics | 2018 |
Characterization and origin of heme precursors in amniotic fluid: lessons from normal and pathological pregnancies
H Manceau, V Puy, CM Schmitt, S Gil, T Lefebvre, B Allaf, J Rosenblatt, L Gouya, H Puy, F Muller, K Peoch |
Pediatric Research | 2018 |
Identification of Endogenous Biomarkers to Predict the Propensity of Drug Candidates to Cause Hepatic or Renal Transporter-Mediated Drug-Drug Interactions
X Chu, GH Chan, R Evers |
Journal of Pharmaceutical Sciences | 2017 |
Coproporphyrins I and III as Functional Markers of OATP1B Activity: In Vitro and In Vivo Evaluation in Preclinical Species
H Shen, J Dai, T Liu, Y Cheng, W Chen, C Freeden, Y Zhang, WG Humphreys, P Marathe, Y Lai |
The Journal of pharmacology and experimental therapeutics | 2016 |
Coproporphyrins in Plasma and Urine Can Be Appropriate Clinical Biomarkers to Recapitulate Drug-Drug Interactions Mediated by Organic Anion Transporting Polypeptide Inhibition
Y Lai, S Mandlekar, H Shen, VK Holenarsipur, R Langish, P Rajanna, S Murugesan, N Gaud, S Selvam, O Date, Y Cheng, P Shipkova, J Dai, WG Humphreys, P Marathe |
The Journal of pharmacology and experimental therapeutics | 2016 |
Emery and Rimoin's Principles and Practice of Medical Genetics
DC Wallace, MT Lott, V Procaccio |
Emery and Rimoin's Principles and Practice of Medical Genetics | 2013 |
Bilirubin Metabolism and Its Disorders
J Roy-Chowdhury, N Roy-Chowdhury |
Zakim and Boyer s Hepatology | 2012 |
Sherlock's Diseases of the Liver and Biliary System
AS Lok |
Sherlock's Diseases of the Liver and Biliary System | 2011 |
Dealing with stress
N Kaplowitz |
Hepatology | 2011 |
Urinary Elimination of Coproporphyrins Is Dependent on ABCC2 Polymorphisms and Represents a Potential Biomarker of MRP2 Activity in Humans
IB Bretagne, R Respaud, P Vourc'h, JM Halimi, A Caille, JS Hulot, CR Andres, CL Guellec |
Journal of Biomedicine and Biotechnology | 2011 |
Hereditary coproporphyria: Comparison of molecular and biochemical investigations in a large family
KR Allen, SD Whatley, TJ Degg, JH Barth |
Journal of Inherited Metabolic Disease | 2005 |
The Porphyrin Handbook
PM Shoolingin-Jordan |
The Porphyrin Handbook | 2003 |
Hepatische Porphyrien und Alkohol
MO Doss, A Kühnel, U Groß, I Sieg |
Medizinische Klinik | 1999 |
Studies on coproporphyrin isomers in urine and feces in the porphyrias
A Kühnel, U Groß, K Jacob, MO Doss |
Clinica Chimica Acta | 1999 |
9 The hereditary hyperbilirubinaemias
MJ Nowicki, JR Poley |
Bailliere's Clinical Gastroenterology | 1998 |
Environmental chemical exposures and disturbances of heme synthesis
WE Daniell, HL Stockbridge, RF Labbe, JS Woods, KE Anderson, DM Bissell, JR Bloomer, RD Ellefson, MR Moore, CA Pierach, WE Schreiber, A Tefferi, GM Franklin |
Environmental Health Perspectives | 1997 |
Molecular Biology of Membrane Transport Disorders
SG Schultz, TE Andreoli, AM Brown, DM Fambrough, JF Hoffman, MJ Welsh |
1996 | |
Excretion Pattern of Faecal Coproporphyrin Isomers I—IV in Human Porphyrias
K Jacob, MO Doss |
Clinical Chemistry and Laboratory Medicine | 1995 |
Altered Urinary Porphyrin Excretion in a Human Po p ulation Chronically Exposed to Arsenic in Mexico
GG García-Vargas, LM Razo, ME Cebrián, A Albores, P Ostrosky-Wegman, R Montero, ME Gonsebatt, CK Lim, FD Matteis |
Human & Experimental Toxicology | 1994 |
Renale und enterale Elimination der Koproporphyrin-Isomeren bei Rotor-Syndrom
H Kellner, WG Zoller, K Jacob, HS Füeßl |
Klinische Wochenschrift | 1988 |
Renale und enterale Elimination der Koproporphyrin-Isomeren bei Rotor-Syndrom: Eine Familienuntersuchung
H Kellner, WG Zoller, K Jacob, HS Füeßl |
Klinische Wochenschrift | 1988 |
Porphyrinurias and Occupational Disease
MO Doss |
Annals of the New York Academy of Sciences | 1987 |
Effects of polychlorinated biphenyls on porphyrin synthesis and cytochrome p—450—dependent monooxygenases in small intestine and liver of Japanese quail
CL Miranda, MC Henderson, JL Wang, HS Nakaue, DR Buhler |
Journal of Toxicology and Environmental Health | 1987 |
Disorders of Porphyrin Metabolism
MR Moore, KE McColl, C Rimington, A Goldberg |
1987 | |
The liver excretes large amounts of heme into bile when heme oxygenase is inhibited competitively by Sn-protoporphyrin
A Kappas, CS Simionatto, GS Drummond, S Sassa, KE Anderson |
Proceedings of the National Academy of Sciences | 1985 |
Alcohol Related Diseases in Gastroenterology
HK Seitz, B Kommerell |
1985 | |
Urinary Coproporphyrin Excretion in Rotor's Syndrome: A Family Study
D Stiel, M Lunzer, V Poulos |
Australian and New Zealand Journal of Medicine | 1982 |
Faecal and urinary coproporphyrin isomers in biliary atresia and neonatal hepatitis
E Rocchi, P Gibertini, V Santunione, F Balli, E Ventura |
La Ricerca in Clinica e in Laboratorio | 1980 |
Hepatic metabolism of bromosulphthalein in porphyria cutanea tarda
RE Salamanca, JM Ladero, T Catalan, V Mas, R Rico, A Olmos |
International Journal of Biochemistry | 1980 |
Rotor's syndrome
AW Wolkoff, E Wolpert, FN Pascasio, IM Arias |
The American Journal of Medicine | 1976 |
Coproporphyrin Isomers in Dubin-Johnson Syndrome
T Kondo, K Kuchiba, Y Shimizu |
Gastroenterology | 1976 |
Separation of the Coprophorphyrin Isomers I and III by Thin-Layer Chromatography
E Schermuly, M Doss |
Clinical Chemistry and Laboratory Medicine | 1975 |
Interaction of rabbit hemopexin with copro- and uroporphyrins
WT Morgan, RP Sutor, U Muller-Eberhard, P Koskelo |
Biochimica et Biophysica Acta (BBA) - Protein Structure | 1975 |
Formation and Elimination of Bilirubin
DM Bissell |
Gastroenterology | 1975 |